Shannon X. Zhao

Statistics

Publications

Citations

317

H-Index

Active since

2000

Affiliations

AstraZeneca (United States)(Current)

Bristol-Myers Squibb (United States)

Shannon X. Zhao is an author at AstraZeneca (United States) specializing in novel antibacterial drug discovery, organic chemistry, and drug discovery.

Publications per year

2000–2018

Publications

Minocycline ameliorates depressive behaviors and neuro-immune dysfunction induced by chronic unpredictable mild stress in the rat

Cai Zhang, Yongping Zhang, Yuyu Li et al. · Behavioural Brain Research · 2018 · 168 citations

Nursing, Neuroscience, Pharmacology +16

Copper(I)-catalyzed intramolecular cyclization reaction of 2-(2′-chlorophenyl)ethanol to give 2,3-dihydrobenzofuran

Jingyang Zhu, Benjamin A. Price, Shannon X. Zhao et al. · Tetrahedron Letters · 2000 · 36 citations

Natural Sciences, Chemistry, Catalysis +7

Discovery of bacterial NAD+-dependent DNA ligase inhibitors: Optimization of antibacterial activity

S. Stokes, Hoan K. Huynh, Madhusudhan Gowravaram et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 34 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +14

SAR and Structural Analysis of Siderophore-Conjugated Monocarbam Inhibitors of <i>Pseudomonas aeruginosa</i> PBP3

Kerry E. Murphy-Benenato, Brian Dangel, Hajnalka E. Davis et al. · ACS Medicinal Chemistry Letters · 2015 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Discovery of Efficacious <i>Pseudomonas aeruginosa</i>-Targeted Siderophore-Conjugated Monocarbams by Application of a Semi-mechanistic Pharmacokinetic/Pharmacodynamic Model

Kerry E. Murphy-Benenato, Pratik Bhagunde, April Chen et al. · Journal of Medicinal Chemistry · 2015 · 27 citations

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 7